Skip to Content
Diagnosed with PsA? Learn about biologics >

Drug interactions between Azithromycin Dose Pack and MethylPREDNISolone Dose Pack

Results for the following 2 drugs:
Azithromycin Dose Pack (azithromycin)
MethylPREDNISolone Dose Pack (methylprednisolone)

Interactions between your drugs

There were no interactions found in our database between Azithromycin Dose Pack and MethylPREDNISolone Dose Pack - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Azithromycin Dose Pack

A total of 441 drugs are known to interact with Azithromycin Dose Pack.

MethylPREDNISolone Dose Pack

A total of 772 drugs are known to interact with MethylPREDNISolone Dose Pack.

Drug and food interactions


methylPREDNISolone food

Applies to: MethylPREDNISolone Dose Pack (methylprednisolone)

Grapefruit juice may increase the blood levels and effects of certain medications such as methylPREDNISolone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with methylPREDNISolone. However, if you have been regularly consuming grapefruit or grapefruit juice with methylPREDNISolone, do not alter the amounts of these products in your diet without first talking to your doctor or other healthcare professional. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.